B‐cell haematological malignancies and SARS‐CoV‐2 infection: Could immunological interventions influence the outcome?

B cell haematological malignancies (HMs) have been described as the worst cancer type for concomitant COVID‐19 in terms of mortality, with rates up to 65%. This risk factor for COVID‐19 cannot only be explained by comorbidities and advanced age of patients, but aggravated by secondary immunodeficien...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochoa‐Grullón, Juliana, Peña Cortijo, Ascensión, Guevara‐Hoyer, Kissy, Jiménez García, Carlos, de la Fuente, Eduardo, de la Peña, Antonia Rodríguez, Fernández‐Arquero, Miguel, González Fernández, Ata, Sánchez‐Ramón, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426868/
https://www.ncbi.nlm.nih.gov/pubmed/34518828
http://dx.doi.org/10.1002/jha2.249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426868/
https://www.ncbi.nlm.nih.gov/pubmed/34518828
http://dx.doi.org/10.1002/jha2.249

Ejemplares similares